Glaukos (GKOS)
(Delayed Data from NYSE)
$112.72 USD
+2.02 (1.82%)
Updated May 31, 2024 04:00 PM ET
After-Market: $112.70 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Glaukos Corporation [GKOS]
Reports for Purchase
Showing records 101 - 120 ( 124 total )
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
4Q Beat and Strong 2017 Growth Outlook Tops Expectations - Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
Healthcare - Med Tech Preannouncement Watch - Look for News into Next Week?s JPM Conference
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Novitas 2017 Schedule Confirms No Change for iStent - Removes Uncertainty
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Final 2017 CMS Rule Confirms Significant iStent Facility Fee Increases
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Sales Momentum Continues with 2Q Beat and 2016 Raise - Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Proposed 2017 CMS Rates Indicate Meaningful Reimbursement Hike for iStent
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
ASCRS Takeaways Indicate Demand for iStent/MIGS Increasingly Strong
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Eye Opening Beat and Raise to Start 2016 - Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C